About Us

About Aūra

Aūra was founded in Colorado by research coordinator Paul Newmann and a small team specializing in analytical review, laboratory workflow, and materials quality assurance. The group observed how limited access was to clean, well-documented research peptides for legitimate scientific use — particularly materials needed for controlled studies involving cellular pathways and metabolic signaling.

Aūra focuses exclusively on supplying laboratory-grade peptide materials intended for in-vitro, ex-vivo, and controlled research environments. The team’s background includes experience in research facilities, analytical labs, and performance testing centers, driving their emphasis on documentation, stability data, and transparent batch reporting — without exaggerated marketing or unverified claims.

At the Aūra facility, mornings begin with routine verification: purity assessment, identity confirmation, and batch logging. Afternoons are dedicated to analytical checks, QC sampling, and validating specifications for consistency. Any material that does not meet internal benchmarks is removed from distribution immediately.

Newmann personally reviews each production lot prior to release. His team — trained in laboratory operations and research-grade handling standards — manages analysis, documentation, and material preparation. Their priority is accuracy and verification: clean, well-characterized peptides prepared for responsible research use only.

“Only materials that meet verification standards are cleared for research distribution.”
— Paul Newmann

Aūra intentionally operates on a small scale to maintain oversight and consistency. Every batch is produced under controlled conditions in Colorado, with a single guiding principle: verification first, purity always. All materials are intended strictly for laboratory research purposes and are not approved for human or veterinary use.